- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands ; volume:3 ; number:5 ; year:2014 ; pages:206-218 ; extent:13
ChemistryOpen ; 3, Heft 5 (2014), 206-218 (gesamt 13)
- Urheber
-
Schaab, Carolin
Kling, Ralf Christian
Einsiedel, Jürgen
Hübner, Harald
Clark, Timothy
Seebach, Dieter
Gmeiner, Peter
- DOI
-
10.1002/open.201402031
- URN
-
urn:nbn:de:101:1-2023011506361529669161
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schaab, Carolin
- Kling, Ralf Christian
- Einsiedel, Jürgen
- Hübner, Harald
- Clark, Timothy
- Seebach, Dieter
- Gmeiner, Peter
Ähnliche Objekte (12)
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands
Evolutionary design of selective adenosine receptor ligands
Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation
Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography
Drug design studies on selective dopamine receptor ligands
Opioid receptor oligomerization study through fluorescent selective ligands
Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands
Development of potent and selective dopamine D3 receptor ligands
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands
Evolutionary design of selective adenosine receptor ligands
Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation
Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography
Drug design studies on selective dopamine receptor ligands
Opioid receptor oligomerization study through fluorescent selective ligands
Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands
Development of potent and selective dopamine D3 receptor ligands
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Synthesis and pharmacological evaluation of enantiomerically pure subtype-selective NMDA receptor modulators
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands
Evolutionary design of selective adenosine receptor ligands
Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation
Development of 18F-labeled subtype selective orexin and muscarinic receptor ligands for imaging by positron emission tomography
Drug design studies on selective dopamine receptor ligands
Opioid receptor oligomerization study through fluorescent selective ligands
Solution and solid phase supported synthesis of 7α-azaindoles [7-alpha-azaindoles] as novel subtype selective dopamine receptor ligands
Development of potent and selective dopamine D3 receptor ligands
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes